Chauvenet, Allen R <br/><br/>
Antimetabolite therapy for lesser-risk B-lineage acute lymphoblastic leukemia of childhood: a report from Children's Oncology Group Study P9201.  [electronic resource] 

 -  Blood  Aug 2007 
 - 1105-11 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0006-4971 
<br/><br/><label>Standard No.: </label>10.1182/blood-2006-12-061689  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Asparaginase--administration & dosage<br/>B-Lymphocytes--drug effects<br/>Cell Lineage<br/>Central Nervous System Neoplasms--prevention & control<br/>Child<br/>Child, Preschool<br/>Disease-Free Survival<br/>Female<br/>Humans<br/>Infant<br/>Infusions, Intravenous<br/>Injections, Intramuscular<br/>Injections, Spinal<br/>Male<br/>Mercaptopurine--administration & dosage<br/>Methotrexate--administration & dosage<br/>Pilot Projects<br/>Precursor Cell Lymphoblastic Leukemia-Lymphoma--drug therapy<br/>Prednisone--administration & dosage<br/>Remission Induction<br/>Treatment Outcome<br/>Vincristine--administration & dosage